Pharma Journalist -

Pfizer declared optimistic outcome from U.S FDA's Gastrointestinal Drugs Advisory Committee (GIDAC) meeting.  The  GIDAC met to discuss Pfizer’s supplemental New Drug Application (sNDA…
Read More...

In a bid to expand its premium Cardiovascular ultrasound system that delivers a complete solution for structural heart analysis, Canon Medical Systems USA has introduced a new version…
Read More...

MiMedx Group which is a leading developer and marketer of regenerative and therapeutic biologics asserted that the U.S Food and Drug Administration has extended MiMedx's micronized…
Read More...

CTI BioPharma Corp asserted that results from the Phase 3 PERSIST-2 clinical Trial of pacritinib which is an investigational JAK22 inhibitor that has been published online in JAMA…
Read More...

FDA approved the conduct of a pivotal Clinical Trial incorporating new technology to treat overactive bladder. The technology, developed and manufactured by Valencia Technologies, is…
Read More...

Amgen revealed that data from two new studies suggest barriers to access for PCSK9 inhibitors and the potential consequences of barring access for PCSK9 inhibitors and the potential…
Read More...

Pharmaceutical Microbiology West Coast is back after a successful launch event in 2017. This year the conference is taking place at the Crowne Plaza San Diego, CA, USA on June 7th and…
Read More...

SMi are delighted to present the 2nd annual Highly Potent Active Pharmaceutical Ingredients (HPAPI) conference being held at Holiday Inn, Kensington Forum, London, on the 21st – 22nd…
Read More...

In order to help ensure more affordable and timely access to patients whose medical needs are unmet , Regeneron Pharmaceuticals and Sanofi will offer payers that agree to lessen…
Read More...

Royal Philips which is a global leader in health technology claimed health economic results from DEFINE FLAIR clinical trial comparing cost-effectiveness between instant wave-free ratio…
Read More...